医学
化脓性链球菌
中毒性休克综合征
链球菌
无乳链球菌
菌血症
马链球菌
A组
微生物学
B组
免疫学
金黄色葡萄球菌
内科学
抗生素
细菌
生物
遗传学
作者
Ahmed Babiker,Sameer S. Kadri
标识
DOI:10.1016/j.idc.2022.07.007
摘要
β-hemolytic streptococci (BHS) are a leading cause of invasive bacterial disease worldwide. They are subtyped based on the presence of the surface polysaccharide antigens and include Group A Streptococcus (GAS; Streptococcus pyogenes), Group B Streptococcus (GBS; Streptococcus agalactiae), and non-group A, non-group B Streptococci (NABS). Invasive BHS infection is defined as isolation from the normally sterile site in patients with a compatible clinical syndrome which include, but is not limited to, streptococcal toxic shock syndrome (STSS), Necrotizing soft tissue infection (NSTI), bacteremia, meningitis lower respiratory tract, musculoskeletal and puerperal/postpartum infections. Resuscitation, source control, and β-lactam therapy are the cornerstone of therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI